Personal tools

FF:10001-101A3: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 37: Line 37:
|id=FF:10001-101A3
|id=FF:10001-101A3
|is_a=EFO:0002091;;FF:0000004;;FF:0000103
|is_a=EFO:0002091;;FF:0000004;;FF:0000103
|is_obsolete=
|name=Clontech Mouse Universal Reference Total RNA, pool1
|name=Clontech Mouse Universal Reference Total RNA, pool1
|namespace=FANTOM5
|namespace=FANTOM5
Line 69: Line 70:
|sample_ethnicity=
|sample_ethnicity=
|sample_experimental_condition=
|sample_experimental_condition=
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;2.15392863424665e-264!GO:0005737;cytoplasm;7.77846402009826e-195!GO:0044444;cytoplasmic part;2.17389085949375e-123!GO:0043226;organelle;4.59215610993726e-104!GO:0043229;intracellular organelle;9.46914176239472e-104!GO:0043227;membrane-bound organelle;2.69818378588046e-94!GO:0043231;intracellular membrane-bound organelle;2.72717209182891e-94!GO:0044422;organelle part;1.56293509719169e-80!GO:0044446;intracellular organelle part;2.75046987567741e-79!GO:0005515;protein binding;2.22869066170654e-72!GO:0032991;macromolecular complex;1.64512896107003e-59!GO:0005739;mitochondrion;2.14331763052161e-52!GO:0016043;cellular component organization and biogenesis;1.16653457493129e-49!GO:0031090;organelle membrane;2.68232578281537e-38!GO:0019538;protein metabolic process;5.54728660859236e-37!GO:0030529;ribonucleoprotein complex;7.22841442458583e-37!GO:0044237;cellular metabolic process;7.26078942457717e-36!GO:0003723;RNA binding;1.04687388938832e-35!GO:0044429;mitochondrial part;1.97955527555451e-35!GO:0043234;protein complex;3.11417419842391e-35!GO:0043233;organelle lumen;1.12498428274729e-34!GO:0031974;membrane-enclosed lumen;1.12498428274729e-34!GO:0031967;organelle envelope;2.23054470980627e-34!GO:0031975;envelope;3.03756439314581e-34!GO:0044238;primary metabolic process;6.98477546743143e-34!GO:0033036;macromolecule localization;1.90449293732481e-33!GO:0044260;cellular macromolecule metabolic process;1.26724247925436e-32!GO:0044428;nuclear part;4.20377213666152e-32!GO:0044267;cellular protein metabolic process;1.33748101070514e-31!GO:0015031;protein transport;1.42803771481416e-31!GO:0008104;protein localization;2.49477461475197e-30!GO:0046907;intracellular transport;2.57892153729705e-30!GO:0045184;establishment of protein localization;1.99746875110498e-29!GO:0005829;cytosol;3.39686004362297e-28!GO:0043170;macromolecule metabolic process;1.54582545309791e-25!GO:0005740;mitochondrial envelope;1.54582545309791e-25!GO:0031966;mitochondrial membrane;2.14794622355338e-25!GO:0065003;macromolecular complex assembly;5.50483273507093e-25!GO:0051641;cellular localization;1.07940705380802e-24!GO:0051649;establishment of cellular localization;1.27755629307056e-24!GO:0022607;cellular component assembly;2.05783610743652e-24!GO:0005840;ribosome;2.21855537614886e-23!GO:0019866;organelle inner membrane;8.45685633623428e-23!GO:0005743;mitochondrial inner membrane;2.82076321313345e-22!GO:0006996;organelle organization and biogenesis;5.22343959814609e-22!GO:0006412;translation;1.01960654318407e-21!GO:0016192;vesicle-mediated transport;1.08229731622916e-21!GO:0006886;intracellular protein transport;1.15197853607914e-21!GO:0016071;mRNA metabolic process;9.37726147210583e-21!GO:0006119;oxidative phosphorylation;3.12190171340634e-20!GO:0003735;structural constituent of ribosome;4.44607062619025e-20!GO:0043228;non-membrane-bound organelle;4.60824053289908e-19!GO:0043232;intracellular non-membrane-bound organelle;4.60824053289908e-19!GO:0009058;biosynthetic process;6.65941411300219e-19!GO:0033279;ribosomal subunit;2.65416658661778e-18!GO:0008380;RNA splicing;2.65416658661778e-18!GO:0031981;nuclear lumen;6.94116719474827e-18!GO:0044249;cellular biosynthetic process;4.23758594779993e-17!GO:0048770;pigment granule;1.13584556362743e-16!GO:0042470;melanosome;1.13584556362743e-16!GO:0006397;mRNA processing;1.5771607132543e-16!GO:0006396;RNA processing;1.83544972877613e-16!GO:0044265;cellular macromolecule catabolic process;1.83744718763735e-16!GO:0044248;cellular catabolic process;2.46300185658617e-16!GO:0009059;macromolecule biosynthetic process;4.07343857001115e-16!GO:0031988;membrane-bound vesicle;6.90309615837938e-16!GO:0031982;vesicle;8.71327850926606e-16!GO:0016023;cytoplasmic membrane-bound vesicle;1.86627622354464e-15!GO:0005773;vacuole;2.44518086193941e-15!GO:0031410;cytoplasmic vesicle;2.4659046646489e-15!GO:0005783;endoplasmic reticulum;3.35009349030428e-15!GO:0005634;nucleus;7.86579018518932e-15!GO:0044455;mitochondrial membrane part;7.59768785665227e-14!GO:0005830;cytosolic ribosome (sensu Eukaryota);8.00359230049322e-14!GO:0005746;mitochondrial respiratory chain;9.53669861995172e-14!GO:0008134;transcription factor binding;1.97043270785569e-13!GO:0000323;lytic vacuole;2.38508810666537e-13!GO:0005764;lysosome;2.38508810666537e-13!GO:0012505;endomembrane system;4.18587139845015e-13!GO:0016874;ligase activity;5.03987970918358e-13!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;5.41801346757542e-13!GO:0051186;cofactor metabolic process;7.83096654372888e-13!GO:0005681;spliceosome;8.29803723094062e-13!GO:0031980;mitochondrial lumen;9.21394812930734e-13!GO:0005759;mitochondrial matrix;9.21394812930734e-13!GO:0050136;NADH dehydrogenase (quinone) activity;1.06074553118194e-12!GO:0003954;NADH dehydrogenase activity;1.06074553118194e-12!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.06074553118194e-12!GO:0000166;nucleotide binding;1.53438800581198e-12!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;3.54944299945681e-12!GO:0006457;protein folding;3.57913133690186e-12!GO:0005794;Golgi apparatus;4.47196817074707e-12!GO:0009057;macromolecule catabolic process;4.67235909639931e-12!GO:0005654;nucleoplasm;5.05982278399328e-12!GO:0044445;cytosolic part;6.41546541888504e-12!GO:0051082;unfolded protein binding;8.63576929044962e-12!GO:0006512;ubiquitin cycle;1.37722651081553e-11!GO:0000502;proteasome complex (sensu Eukaryota);2.03161341909796e-11!GO:0009055;electron carrier activity;2.07694496810625e-11!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;4.10055334068277e-11!GO:0006732;coenzyme metabolic process;4.10055334068277e-11!GO:0030964;NADH dehydrogenase complex (quinone);9.36746144610411e-11!GO:0045271;respiratory chain complex I;9.36746144610411e-11!GO:0005747;mitochondrial respiratory chain complex I;9.36746144610411e-11!GO:0051603;proteolysis involved in cellular protein catabolic process;9.74637189991183e-11!GO:0048193;Golgi vesicle transport;1.01526155798164e-10!GO:0008565;protein transporter activity;1.19868059989831e-10!GO:0009056;catabolic process;1.7295512695538e-10!GO:0019941;modification-dependent protein catabolic process;1.77603803932196e-10!GO:0043632;modification-dependent macromolecule catabolic process;1.77603803932196e-10!GO:0042775;organelle ATP synthesis coupled electron transport;1.79812090701118e-10!GO:0042773;ATP synthesis coupled electron transport;1.79812090701118e-10!GO:0022618;protein-RNA complex assembly;2.20892629797398e-10!GO:0006511;ubiquitin-dependent protein catabolic process;2.20892629797398e-10!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;2.43158100494746e-10!GO:0008092;cytoskeletal protein binding;2.47610437097422e-10!GO:0006461;protein complex assembly;2.52166416372963e-10!GO:0044257;cellular protein catabolic process;2.78245066398443e-10!GO:0015935;small ribosomal subunit;4.47497493214057e-10!GO:0005635;nuclear envelope;5.74853126661183e-10!GO:0006605;protein targeting;6.48375959215487e-10!GO:0016462;pyrophosphatase activity;6.58966346854131e-10!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;6.81840987491691e-10!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;6.91120178211206e-10!GO:0016044;membrane organization and biogenesis;8.13789524434768e-10!GO:0016817;hydrolase activity, acting on acid anhydrides;8.16144269022215e-10!GO:0006464;protein modification process;1.00797698920006e-09!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.03179040883371e-09!GO:0043412;biopolymer modification;1.30208050870298e-09!GO:0006793;phosphorus metabolic process;1.51207665171125e-09!GO:0006796;phosphate metabolic process;1.51207665171125e-09!GO:0019829;cation-transporting ATPase activity;1.65266928153075e-09!GO:0043687;post-translational protein modification;1.92568910646232e-09!GO:0006913;nucleocytoplasmic transport;2.10290150733994e-09!GO:0044451;nucleoplasm part;2.21134185523196e-09!GO:0017111;nucleoside-triphosphatase activity;2.26986369096349e-09!GO:0044432;endoplasmic reticulum part;2.26986369096349e-09!GO:0015934;large ribosomal subunit;3.77633818777602e-09!GO:0051169;nuclear transport;5.16297105675451e-09!GO:0015630;microtubule cytoskeleton;6.09995870439872e-09!GO:0015986;ATP synthesis coupled proton transport;6.1724568532547e-09!GO:0015985;energy coupled proton transport, down electrochemical gradient;6.1724568532547e-09!GO:0030036;actin cytoskeleton organization and biogenesis;7.23463903095207e-09!GO:0007010;cytoskeleton organization and biogenesis;1.41625486701664e-08!GO:0008135;translation factor activity, nucleic acid binding;1.45393115662613e-08!GO:0005768;endosome;2.5007326352606e-08!GO:0009060;aerobic respiration;3.27953767417054e-08!GO:0043285;biopolymer catabolic process;3.46663535689483e-08!GO:0031965;nuclear membrane;4.13022598608399e-08!GO:0017076;purine nucleotide binding;4.32867359075165e-08!GO:0045333;cellular respiration;4.81122314458772e-08!GO:0006446;regulation of translational initiation;5.81906448277055e-08!GO:0030163;protein catabolic process;5.99942060239103e-08!GO:0003712;transcription cofactor activity;7.30495343647884e-08!GO:0008639;small protein conjugating enzyme activity;7.72796840643676e-08!GO:0048523;negative regulation of cellular process;8.58580855649813e-08!GO:0032553;ribonucleotide binding;8.91525856726441e-08!GO:0032555;purine ribonucleotide binding;8.91525856726441e-08!GO:0004842;ubiquitin-protein ligase activity;9.03558993813206e-08!GO:0019787;small conjugating protein ligase activity;1.14277821091936e-07!GO:0006323;DNA packaging;1.15704380353971e-07!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);1.20787532694136e-07!GO:0030029;actin filament-based process;1.71759892810485e-07!GO:0051246;regulation of protein metabolic process;1.72877755797994e-07!GO:0016491;oxidoreductase activity;1.92803506978606e-07!GO:0051179;localization;2.11306619030859e-07!GO:0016881;acid-amino acid ligase activity;2.11348181606264e-07!GO:0007049;cell cycle;2.22776078639441e-07!GO:0016469;proton-transporting two-sector ATPase complex;2.43904632776639e-07!GO:0000398;nuclear mRNA splicing, via spliceosome;2.52292558125171e-07!GO:0000375;RNA splicing, via transesterification reactions;2.52292558125171e-07!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;2.52292558125171e-07!GO:0006099;tricarboxylic acid cycle;2.56196839755648e-07!GO:0046356;acetyl-CoA catabolic process;2.56196839755648e-07!GO:0016879;ligase activity, forming carbon-nitrogen bonds;2.69261526669267e-07!GO:0015078;hydrogen ion transmembrane transporter activity;2.7727753316557e-07!GO:0006325;establishment and/or maintenance of chromatin architecture;3.04917931400087e-07!GO:0051187;cofactor catabolic process;3.72391270795031e-07!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);5.25483688699682e-07!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.81975862220308e-07!GO:0005789;endoplasmic reticulum membrane;5.81975862220308e-07!GO:0006754;ATP biosynthetic process;6.25323924321736e-07!GO:0006753;nucleoside phosphate metabolic process;6.25323924321736e-07!GO:0045045;secretory pathway;6.48106715322393e-07!GO:0046034;ATP metabolic process;7.3224595402276e-07!GO:0016604;nuclear body;7.98481797503077e-07!GO:0006082;organic acid metabolic process;8.480083717737e-07!GO:0006091;generation of precursor metabolites and energy;9.01235598365598e-07!GO:0005793;ER-Golgi intermediate compartment;9.4293851040249e-07!GO:0009109;coenzyme catabolic process;1.02420224172069e-06!GO:0005761;mitochondrial ribosome;1.05803598770485e-06!GO:0000313;organellar ribosome;1.05803598770485e-06!GO:0005643;nuclear pore;1.08270608475256e-06!GO:0016310;phosphorylation;1.20620852088935e-06!GO:0031252;leading edge;1.43964176136219e-06!GO:0019752;carboxylic acid metabolic process;1.57574715697766e-06!GO:0048519;negative regulation of biological process;1.59550809166755e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;1.72775036845934e-06!GO:0006413;translational initiation;1.78398282301458e-06!GO:0044453;nuclear membrane part;1.83575476371291e-06!GO:0009205;purine ribonucleoside triphosphate metabolic process;2.40041204700287e-06!GO:0009144;purine nucleoside triphosphate metabolic process;2.40041204700287e-06!GO:0009199;ribonucleoside triphosphate metabolic process;2.47539886804751e-06!GO:0006810;transport;2.53119031006509e-06!GO:0019318;hexose metabolic process;2.6598507548039e-06!GO:0006897;endocytosis;2.73898983395765e-06!GO:0010324;membrane invagination;2.73898983395765e-06!GO:0006084;acetyl-CoA metabolic process;2.73898983395765e-06!GO:0050657;nucleic acid transport;3.18627460992733e-06!GO:0051236;establishment of RNA localization;3.18627460992733e-06!GO:0050658;RNA transport;3.18627460992733e-06!GO:0048475;coated membrane;3.33730624927433e-06!GO:0030117;membrane coat;3.33730624927433e-06!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;3.34011675428301e-06!GO:0009145;purine nucleoside triphosphate biosynthetic process;3.34011675428301e-06!GO:0016607;nuclear speck;3.48733130296348e-06!GO:0009142;nucleoside triphosphate biosynthetic process;3.5149549288597e-06!GO:0009201;ribonucleoside triphosphate biosynthetic process;3.5149549288597e-06!GO:0003779;actin binding;3.53813548432296e-06!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;3.59257471123602e-06!GO:0003924;GTPase activity;3.8409230055408e-06!GO:0009141;nucleoside triphosphate metabolic process;3.8409230055408e-06!GO:0015980;energy derivation by oxidation of organic compounds;3.85689651829847e-06!GO:0005996;monosaccharide metabolic process;3.87511286794794e-06!GO:0006403;RNA localization;4.30853294110165e-06!GO:0009259;ribonucleotide metabolic process;4.6357631268551e-06!GO:0006007;glucose catabolic process;4.86265797898063e-06!GO:0009150;purine ribonucleotide metabolic process;5.26540131019113e-06!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;5.319081004718e-06!GO:0009152;purine ribonucleotide biosynthetic process;6.97471842953124e-06!GO:0006006;glucose metabolic process;7.13542231867179e-06!GO:0017038;protein import;7.24366758172698e-06!GO:0006163;purine nucleotide metabolic process;7.62725866396584e-06!GO:0005905;coated pit;8.03172847588522e-06!GO:0009260;ribonucleotide biosynthetic process;8.2457982159799e-06!GO:0008219;cell death;8.85569109303345e-06!GO:0016265;death;8.85569109303345e-06!GO:0006333;chromatin assembly or disassembly;9.44694217005646e-06!GO:0048471;perinuclear region of cytoplasm;9.51089698797933e-06!GO:0006752;group transfer coenzyme metabolic process;1.00643959550186e-05!GO:0051276;chromosome organization and biogenesis;1.01947803216507e-05!GO:0006164;purine nucleotide biosynthetic process;1.0727452898538e-05!GO:0012501;programmed cell death;1.16223728568211e-05!GO:0019899;enzyme binding;1.21558257203292e-05!GO:0022890;inorganic cation transmembrane transporter activity;1.22600045841185e-05!GO:0006259;DNA metabolic process;1.26621820133397e-05!GO:0005730;nucleolus;1.30219984189534e-05!GO:0006915;apoptosis;1.42328454591933e-05!GO:0043283;biopolymer metabolic process;1.44509374645854e-05!GO:0051234;establishment of localization;1.55671759230004e-05!GO:0044440;endosomal part;1.57036920219977e-05!GO:0010008;endosome membrane;1.57036920219977e-05!GO:0022402;cell cycle process;1.6486099647964e-05!GO:0046164;alcohol catabolic process;1.72323408031108e-05!GO:0006888;ER to Golgi vesicle-mediated transport;1.83416108813248e-05!GO:0005525;GTP binding;1.87778760776178e-05!GO:0044262;cellular carbohydrate metabolic process;1.96134371226725e-05!GO:0043069;negative regulation of programmed cell death;2.15644487855753e-05!GO:0030554;adenyl nucleotide binding;2.76510467589909e-05!GO:0043066;negative regulation of apoptosis;2.77218830182156e-05!GO:0005839;proteasome core complex (sensu Eukaryota);3.04759556842967e-05!GO:0046365;monosaccharide catabolic process;3.11125338240265e-05!GO:0000785;chromatin;3.23137403964701e-05!GO:0005741;mitochondrial outer membrane;3.2668960206855e-05!GO:0006066;alcohol metabolic process;3.30106416105181e-05!GO:0019320;hexose catabolic process;3.69335263414909e-05!GO:0044275;cellular carbohydrate catabolic process;3.79014792127074e-05!GO:0005874;microtubule;3.93021746197374e-05!GO:0032940;secretion by cell;3.94281384190385e-05!GO:0003743;translation initiation factor activity;4.00388758709012e-05!GO:0042623;ATPase activity, coupled;4.06705010541559e-05!GO:0030120;vesicle coat;4.26789662766686e-05!GO:0030662;coated vesicle membrane;4.26789662766686e-05!GO:0006916;anti-apoptosis;4.43865755729106e-05!GO:0032559;adenyl ribonucleotide binding;4.52330461620561e-05!GO:0051028;mRNA transport;4.55599942788293e-05!GO:0046930;pore complex;4.76011853074159e-05!GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors;4.78294981152477e-05!GO:0006366;transcription from RNA polymerase II promoter;4.84968163855825e-05!GO:0065004;protein-DNA complex assembly;5.33269513335431e-05!GO:0045259;proton-transporting ATP synthase complex;5.57898656964333e-05!GO:0005524;ATP binding;6.72226800810278e-05!GO:0005770;late endosome;7.45858150609295e-05!GO:0051287;NAD binding;7.49101642608133e-05!GO:0042802;identical protein binding;8.60096482036487e-05!GO:0006096;glycolysis;8.84377147120688e-05!GO:0008654;phospholipid biosynthetic process;8.9235842950412e-05!GO:0031497;chromatin assembly;9.23509472583355e-05!GO:0006606;protein import into nucleus;9.54739984397394e-05!GO:0031968;organelle outer membrane;9.80519509912217e-05!GO:0051170;nuclear import;0.000103308652319701!GO:0006334;nucleosome assembly;0.000108948283723452!GO:0005774;vacuolar membrane;0.000108948283723452!GO:0016887;ATPase activity;0.000123926303282691!GO:0044437;vacuolar part;0.000124488523440953!GO:0019867;outer membrane;0.00015476246724227!GO:0050662;coenzyme binding;0.000158541310893593!GO:0000786;nucleosome;0.000177994887928299!GO:0016049;cell growth;0.000181682487139269!GO:0003713;transcription coactivator activity;0.000181682487139269!GO:0065002;intracellular protein transport across a membrane;0.00018170412289949!GO:0016564;transcription repressor activity;0.000186446867276533!GO:0044255;cellular lipid metabolic process;0.000188965257473572!GO:0008361;regulation of cell size;0.000198588690390861!GO:0004298;threonine endopeptidase activity;0.000234651437135107!GO:0006613;cotranslational protein targeting to membrane;0.00023891533958397!GO:0032446;protein modification by small protein conjugation;0.000258283710980608!GO:0015631;tubulin binding;0.000260748144179781!GO:0005815;microtubule organizing center;0.000288197725487633!GO:0030135;coated vesicle;0.000296826590261017!GO:0032561;guanyl ribonucleotide binding;0.000304627778271904!GO:0019001;guanyl nucleotide binding;0.000304627778271904!GO:0051168;nuclear export;0.000318930909981485!GO:0007264;small GTPase mediated signal transduction;0.000330022910773801!GO:0003724;RNA helicase activity;0.000335498423111625!GO:0045786;negative regulation of progression through cell cycle;0.000353464931750557!GO:0003714;transcription corepressor activity;0.00035453686180489!GO:0016567;protein ubiquitination;0.000372013693531137!GO:0001666;response to hypoxia;0.000374251150016116!GO:0030133;transport vesicle;0.000389750504347133!GO:0043623;cellular protein complex assembly;0.000426170450732427!GO:0008026;ATP-dependent helicase activity;0.000446117504198102!GO:0051128;regulation of cellular component organization and biogenesis;0.000459885851085558!GO:0048037;cofactor binding;0.000468993934588687!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.000515289809466633!GO:0051188;cofactor biosynthetic process;0.000523080381556796!GO:0001558;regulation of cell growth;0.000530574027218364!GO:0005813;centrosome;0.000560700836605482!GO:0030532;small nuclear ribonucleoprotein complex;0.000586447523892758!GO:0051789;response to protein stimulus;0.000604858442138794!GO:0006986;response to unfolded protein;0.000604858442138794!GO:0000245;spliceosome assembly;0.000620721827847918!GO:0008610;lipid biosynthetic process;0.000620721827847918!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000678614393458275!GO:0030118;clathrin coat;0.000706580278383973!GO:0031072;heat shock protein binding;0.000728209891314954!GO:0008154;actin polymerization and/or depolymerization;0.000801529010978352!GO:0032787;monocarboxylic acid metabolic process;0.000818369053397559!GO:0000151;ubiquitin ligase complex;0.000850807590540518!GO:0051427;hormone receptor binding;0.000936254125941103!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.000936733376101918!GO:0016052;carbohydrate catabolic process;0.000936733376101918!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.000936733376101918!GO:0015399;primary active transmembrane transporter activity;0.000936733376101918!GO:0005856;cytoskeleton;0.000939907060107742!GO:0009892;negative regulation of metabolic process;0.000955645756998169!GO:0009108;coenzyme biosynthetic process;0.00100654023605352!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.00104413875584985!GO:0005798;Golgi-associated vesicle;0.00112512729904337!GO:0004386;helicase activity;0.00114160140117524!GO:0045454;cell redox homeostasis;0.00114853531270018!GO:0005083;small GTPase regulator activity;0.00125311881286869!GO:0042995;cell projection;0.00125988143335174!GO:0008186;RNA-dependent ATPase activity;0.00137508020471345!GO:0046467;membrane lipid biosynthetic process;0.00142588189925939!GO:0016791;phosphoric monoester hydrolase activity;0.00146139682814319!GO:0006643;membrane lipid metabolic process;0.0015384493065998!GO:0035257;nuclear hormone receptor binding;0.00166674506651002!GO:0004364;glutathione transferase activity;0.00166674506651002!GO:0008287;protein serine/threonine phosphatase complex;0.00173032304409622!GO:0005788;endoplasmic reticulum lumen;0.00176311837001263!GO:0005975;carbohydrate metabolic process;0.00176648294983688!GO:0042981;regulation of apoptosis;0.00180316946795702!GO:0006414;translational elongation;0.00185090156438652!GO:0016568;chromatin modification;0.0018863747460284!GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;0.0019201428311664!GO:0051920;peroxiredoxin activity;0.00199247525755233!GO:0006629;lipid metabolic process;0.00199828207929914!GO:0005048;signal sequence binding;0.00212743115373414!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.00223063227175552!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0022337308202427!GO:0043067;regulation of programmed cell death;0.00223955378861879!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.00225467100437343!GO:0044431;Golgi apparatus part;0.00225467100437343!GO:0008250;oligosaccharyl transferase complex;0.00226232049312676!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00228418883995131!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00228418883995131!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00228418883995131!GO:0043492;ATPase activity, coupled to movement of substances;0.00232534219028821!GO:0005765;lysosomal membrane;0.00239457480895947!GO:0016563;transcription activator activity;0.00243628315995152!GO:0031324;negative regulation of cellular metabolic process;0.00250064203229005!GO:0030695;GTPase regulator activity;0.00264399219984573!GO:0003729;mRNA binding;0.00266064849095567!GO:0030027;lamellipodium;0.00271178945215348!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.00280274469356283!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.00282189976566861!GO:0030867;rough endoplasmic reticulum membrane;0.00288863898419035!GO:0005875;microtubule associated complex;0.00289907557239119!GO:0051726;regulation of cell cycle;0.00300371595869953!GO:0016311;dephosphorylation;0.0030172502524691!GO:0005791;rough endoplasmic reticulum;0.00303139041563066!GO:0007286;spermatid development;0.00303737582149737!GO:0006595;polyamine metabolic process;0.00306105917256875!GO:0003697;single-stranded DNA binding;0.00327728673843973!GO:0043566;structure-specific DNA binding;0.00341478713118452!GO:0008286;insulin receptor signaling pathway;0.00342026565663065!GO:0033673;negative regulation of kinase activity;0.00342337970138233!GO:0006469;negative regulation of protein kinase activity;0.00342337970138233!GO:0019208;phosphatase regulator activity;0.0034858446960308!GO:0001726;ruffle;0.00364250881325671!GO:0007017;microtubule-based process;0.003661661107004!GO:0004004;ATP-dependent RNA helicase activity;0.00368776134262608!GO:0007265;Ras protein signal transduction;0.00370547186507156!GO:0016126;sterol biosynthetic process;0.0038209884692708!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.00393161214207354!GO:0004812;aminoacyl-tRNA ligase activity;0.00393161214207354!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.00393161214207354!GO:0008047;enzyme activator activity;0.00405972434464462!GO:0000074;regulation of progression through cell cycle;0.00412877181206546!GO:0006612;protein targeting to membrane;0.00413667186995018!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00421348043218316!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;0.00447157153161413!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.00460342654764889!GO:0015002;heme-copper terminal oxidase activity;0.00460342654764889!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.00460342654764889!GO:0004129;cytochrome-c oxidase activity;0.00460342654764889!GO:0006631;fatty acid metabolic process;0.00492593062009696!GO:0006607;NLS-bearing substrate import into nucleus;0.00507214548989943!GO:0006100;tricarboxylic acid cycle intermediate metabolic process;0.00508739203014697!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;0.00521481867820711!GO:0051674;localization of cell;0.00524322339284968!GO:0006928;cell motility;0.00524322339284968!GO:0048487;beta-tubulin binding;0.00541982958359708!GO:0046903;secretion;0.00583548081224608!GO:0043407;negative regulation of MAP kinase activity;0.00584906807176142!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.00615393505553025!GO:0008139;nuclear localization sequence binding;0.00617288850529659!GO:0000059;protein import into nucleus, docking;0.00625071714008012!GO:0048515;spermatid differentiation;0.00632464629348931!GO:0006979;response to oxidative stress;0.00632699985399745!GO:0019904;protein domain specific binding;0.00643187450046754!GO:0005769;early endosome;0.00645040924039446!GO:0043038;amino acid activation;0.00652491348625434!GO:0006418;tRNA aminoacylation for protein translation;0.00652491348625434!GO:0043039;tRNA aminoacylation;0.00652491348625434!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00662982190949039!GO:0005885;Arp2/3 protein complex;0.00662982190949039!GO:0033116;ER-Golgi intermediate compartment membrane;0.0069427201522551!GO:0006650;glycerophospholipid metabolic process;0.00694665376982694!GO:0004576;oligosaccharyl transferase activity;0.00714358684105208!GO:0043488;regulation of mRNA stability;0.00727759358232797!GO:0043487;regulation of RNA stability;0.00727759358232797!GO:0045187;regulation of circadian sleep/wake cycle, sleep;0.00730206667451679!GO:0004667;prostaglandin-D synthase activity;0.00730206667451679!GO:0050802;circadian sleep/wake cycle, sleep;0.00730206667451679!GO:0022410;circadian sleep/wake cycle process;0.00730206667451679!GO:0042749;regulation of circadian sleep/wake cycle;0.00730206667451679!GO:0003746;translation elongation factor activity;0.00741564805947398!GO:0031902;late endosome membrane;0.00779017896224312!GO:0016197;endosome transport;0.00779017896224312!GO:0004029;aldehyde dehydrogenase (NAD) activity;0.00787178299145772!GO:0012506;vesicle membrane;0.00792991598497488!GO:0004300;enoyl-CoA hydratase activity;0.00794489327871365!GO:0051087;chaperone binding;0.00808637798806436!GO:0051258;protein polymerization;0.00829186727831284!GO:0006818;hydrogen transport;0.00838654119961399!GO:0004674;protein serine/threonine kinase activity;0.00884463368377851!GO:0004177;aminopeptidase activity;0.00890542097673614!GO:0005762;mitochondrial large ribosomal subunit;0.00902321462960018!GO:0000315;organellar large ribosomal subunit;0.00902321462960018!GO:0016481;negative regulation of transcription;0.00909795444099833!GO:0015992;proton transport;0.009188536644387!GO:0035258;steroid hormone receptor binding;0.00928431054833049!GO:0019843;rRNA binding;0.00937443096072272!GO:0017166;vinculin binding;0.00940597039849956!GO:0051348;negative regulation of transferase activity;0.00959627807821149!GO:0051248;negative regulation of protein metabolic process;0.00965632954707399!GO:0019888;protein phosphatase regulator activity;0.00994377829580578!GO:0016301;kinase activity;0.01002507828151!GO:0030100;regulation of endocytosis;0.0100571731066037!GO:0006898;receptor-mediated endocytosis;0.0101791507645722!GO:0006891;intra-Golgi vesicle-mediated transport;0.0102086454894822!GO:0051129;negative regulation of cellular component organization and biogenesis;0.0103146252265486!GO:0006402;mRNA catabolic process;0.0103424328592792!GO:0030041;actin filament polymerization;0.0103591040251713!GO:0010467;gene expression;0.0103883390592653!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.0106092173582287!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.0106796913688639!GO:0030139;endocytic vesicle;0.0109847737364167!GO:0043021;ribonucleoprotein binding;0.0109847737364167!GO:0000902;cell morphogenesis;0.0115743374517828!GO:0032989;cellular structure morphogenesis;0.0115743374517828!GO:0044433;cytoplasmic vesicle part;0.0115743374517828!GO:0006749;glutathione metabolic process;0.011578884067238!GO:0006767;water-soluble vitamin metabolic process;0.0116847444678348!GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;0.0119003000819246!GO:0007243;protein kinase cascade;0.0121349904116067!GO:0030518;steroid hormone receptor signaling pathway;0.0125495893357782!GO:0044427;chromosomal part;0.0128978860100351!GO:0048468;cell development;0.0130971132033854!GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;0.0131069546818683!GO:0004721;phosphoprotein phosphatase activity;0.0131069546818683!GO:0005667;transcription factor complex;0.0134431134274129!GO:0046474;glycerophospholipid biosynthetic process;0.013470921833977!GO:0030132;clathrin coat of coated pit;0.0136194578006015!GO:0046488;phosphatidylinositol metabolic process;0.0140108121872073!GO:0008017;microtubule binding;0.0140108121872073!GO:0016740;transferase activity;0.0147843789753457!GO:0006405;RNA export from nucleus;0.014844715418116!GO:0031124;mRNA 3'-end processing;0.0152983658821529!GO:0018196;peptidyl-asparagine modification;0.0155022525428532!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.0155022525428532!GO:0051540;metal cluster binding;0.0155631491351666!GO:0051536;iron-sulfur cluster binding;0.0155631491351666!GO:0006644;phospholipid metabolic process;0.0155748585690566!GO:0048154;S100 beta binding;0.0157763006932211!GO:0043209;myelin sheath;0.0162888521894972!GO:0005869;dynactin complex;0.0167173185326075!GO:0006665;sphingolipid metabolic process;0.0169103176976285!GO:0005777;peroxisome;0.0170505458772636!GO:0042579;microbody;0.0170505458772636!GO:0000159;protein phosphatase type 2A complex;0.0173190047374526!GO:0007272;ensheathment of neurons;0.0174540890944943!GO:0008366;axon ensheathment;0.0174540890944943!GO:0019887;protein kinase regulator activity;0.0176953502343791!GO:0005096;GTPase activator activity;0.0179589760541996!GO:0003988;acetyl-CoA C-acyltransferase activity;0.0183176411881518!GO:0019902;phosphatase binding;0.019064198260057!GO:0006695;cholesterol biosynthetic process;0.0193590646901727!GO:0000096;sulfur amino acid metabolic process;0.0196421869256742!GO:0015629;actin cytoskeleton;0.0198096980951347!GO:0045892;negative regulation of transcription, DNA-dependent;0.0206155202503517!GO:0004680;casein kinase activity;0.0214002986073729!GO:0030658;transport vesicle membrane;0.0214023579153657!GO:0030659;cytoplasmic vesicle membrane;0.0214549588751965!GO:0006635;fatty acid beta-oxidation;0.0215084903017451!GO:0043284;biopolymer biosynthetic process;0.0216522336344091!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0216749706837665!GO:0030127;COPII vesicle coat;0.0216749706837665!GO:0012507;ER to Golgi transport vesicle membrane;0.0216749706837665!GO:0030134;ER to Golgi transport vesicle;0.0218691583709305!GO:0051252;regulation of RNA metabolic process;0.0222533948496206!GO:0050811;GABA receptor binding;0.0223785712749764!GO:0007005;mitochondrion organization and biogenesis;0.0223819056379941!GO:0006596;polyamine biosynthetic process;0.0228776129213693!GO:0030865;cortical cytoskeleton organization and biogenesis;0.0231098273992012!GO:0016787;hydrolase activity;0.0239274316596845!GO:0035042;fertilization, exchange of chromosomal proteins;0.0240568226924047!GO:0035041;sperm chromatin decondensation;0.0240568226924047!GO:0007050;cell cycle arrest;0.0240568226924047!GO:0035035;histone acetyltransferase binding;0.0241719167882783!GO:0040008;regulation of growth;0.0241719167882783!GO:0051261;protein depolymerization;0.02420714214425!GO:0006118;electron transport;0.025754835314714!GO:0006672;ceramide metabolic process;0.0258986832505077!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0261381448596955!GO:0008601;protein phosphatase type 2A regulator activity;0.0266632578686021!GO:0000278;mitotic cell cycle;0.0285246383146959!GO:0008144;drug binding;0.028853887879727!GO:0000139;Golgi membrane;0.0290023427964867!GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;0.0301752021361382!GO:0045792;negative regulation of cell size;0.0301752021361382!GO:0031901;early endosome membrane;0.0309785685916502!GO:0006611;protein export from nucleus;0.0309903170332244!GO:0000314;organellar small ribosomal subunit;0.0309903170332244!GO:0005763;mitochondrial small ribosomal subunit;0.0309903170332244!GO:0015036;disulfide oxidoreductase activity;0.0313367573257824!GO:0005952;cAMP-dependent protein kinase complex;0.0313367573257824!GO:0005832;chaperonin-containing T-complex;0.0331009190840037!GO:0030660;Golgi-associated vesicle membrane;0.0334574665870728!GO:0019207;kinase regulator activity;0.0338379954502694!GO:0048500;signal recognition particle;0.0345365050700946!GO:0045893;positive regulation of transcription, DNA-dependent;0.0348149876040161!GO:0022406;membrane docking;0.0351753379218803!GO:0048278;vesicle docking;0.0351753379218803!GO:0008147;structural constituent of bone;0.0351753379218803!GO:0006892;post-Golgi vesicle-mediated transport;0.0356315962807424!GO:0009117;nucleotide metabolic process;0.0358839056348674!GO:0008553;hydrogen-exporting ATPase activity, phosphorylative mechanism;0.0360886701510801!GO:0016830;carbon-carbon lyase activity;0.0361796748124853!GO:0008064;regulation of actin polymerization and/or depolymerization;0.0366465279893229!GO:0006470;protein amino acid dephosphorylation;0.0369562866292961!GO:0008603;cAMP-dependent protein kinase regulator activity;0.0369562866292961!GO:0005852;eukaryotic translation initiation factor 3 complex;0.0369562866292961!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.0369562866292961!GO:0033043;regulation of organelle organization and biogenesis;0.0369562866292961!GO:0005862;muscle thin filament tropomyosin;0.03740771472975!GO:0005938;cell cortex;0.0376816927060584!GO:0005868;cytoplasmic dynein complex;0.0377798302053814!GO:0030137;COPI-coated vesicle;0.0377851457465595!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0378337100355012!GO:0030119;AP-type membrane coat adaptor complex;0.0378797834015805!GO:0008022;protein C-terminus binding;0.0387418558765091!GO:0008073;ornithine decarboxylase inhibitor activity;0.0392108195788003!GO:0016363;nuclear matrix;0.0394258921807498!GO:0030308;negative regulation of cell growth;0.0394258921807498!GO:0051017;actin filament bundle formation;0.0396599179243066!GO:0046519;sphingoid metabolic process;0.0397310970351122!GO:0009081;branched chain family amino acid metabolic process;0.0405717005386051!GO:0005694;chromosome;0.0408552178704014!GO:0030663;COPI coated vesicle membrane;0.0409556550704781!GO:0030126;COPI vesicle coat;0.0409556550704781!GO:0005853;eukaryotic translation elongation factor 1 complex;0.041103841101427!GO:0007019;microtubule depolymerization;0.04119985667167!GO:0009066;aspartate family amino acid metabolic process;0.0414547731704759!GO:0030320;cellular monovalent inorganic anion homeostasis;0.0414547731704759!GO:0055083;monovalent inorganic anion homeostasis;0.0414547731704759!GO:0055064;chloride ion homeostasis;0.0414547731704759!GO:0030644;cellular chloride ion homeostasis;0.0414547731704759!GO:0009966;regulation of signal transduction;0.0419430440941231!GO:0031123;RNA 3'-end processing;0.043289742936852!GO:0042979;ornithine decarboxylase regulator activity;0.0433171557300285!GO:0000062;acyl-CoA binding;0.0433777583756501!GO:0016773;phosphotransferase activity, alcohol group as acceptor;0.0435117498314923!GO:0050749;apolipoprotein E receptor binding;0.0435117498314923!GO:0030131;clathrin adaptor complex;0.0436796742783759!GO:0008238;exopeptidase activity;0.0437268991339032!GO:0043681;protein import into mitochondrion;0.0439544582948625!GO:0006904;vesicle docking during exocytosis;0.0440563789397529!GO:0030384;phosphoinositide metabolic process;0.0440563789397529!GO:0006661;phosphatidylinositol biosynthetic process;0.0450263885274613!GO:0007040;lysosome organization and biogenesis;0.0450263885274613!GO:0022403;cell cycle phase;0.0450263885274613!GO:0046483;heterocycle metabolic process;0.0450263885274613!GO:0016050;vesicle organization and biogenesis;0.0451359559703965!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0451359559703965!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0451359559703965!GO:0007249;I-kappaB kinase/NF-kappaB cascade;0.0461084247550119!GO:0016624;oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor;0.0465047861112346!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0465047861112346!GO:0065009;regulation of a molecular function;0.0466824298538351!GO:0030522;intracellular receptor-mediated signaling pathway;0.0477529031215495!GO:0016584;nucleosome positioning;0.0495939080939392
|sample_id=10001
|sample_id=10001
|sample_note=
|sample_note=
Line 76: Line 78:
|sample_tissue=whole body
|sample_tissue=whole body
|top_motifs=JUN:5.6915083538;SOX17:5.358292647;HLF:4.77768514715;RFX2..5_RFXANK_RFXAP:4.75200277899;RFX1:4.5617862975;MYB:4.53705025272;ATF2:3.64593667106;HSF1,2:3.57284584026;ESR1:2.90129344504;PPARG:2.53309877243;NFE2L1:2.28758296935;FOXN1:2.28286887152;HBP1_HMGB_SSRP1_UBTF:2.20473348062;NFIL3:2.18174138979;HOXA9_MEIS1:1.68794996479;TBX4,5:1.40970850168;NR1H4:1.17709342086;NR3C1:1.07325017827;ZBTB6:1.03155343269;PAX5:1.02489809041;NRF1:1.00725451332;BREu{core}:0.91469774455;REST:0.850647514045;bHLH_family:0.715522171398;TFAP2{A,C}:0.70922832969;ATF5_CREB3:0.705145086545;ATF4:0.690382436545;HIC1:0.678025160783;PAX6:0.659244820276;STAT1,3:0.637957662372;GLI1..3:0.635984491192;CUX2:0.635516946133;NKX3-2:0.619466382383;NFY{A,B,C}:0.619434338994;HIF1A:0.616409008276;PRRX1,2:0.611993703609;RBPJ:0.60363292854;PATZ1:0.594233728141;ESRRA:0.58795523654;HES1:0.582834868648;TFAP2B:0.574009740051;ZEB1:0.567484714213;AR:0.428232907826;HNF1A:0.373954313919;AHR_ARNT_ARNT2:0.364109717386;FOXO1,3,4:0.356702000803;POU6F1:0.338550358847;OCT4_SOX2{dimer}:0.33190447989;MTE{core}:0.27085953884;HAND1,2:0.263080264516;GFI1:0.259346090379;SMAD1..7,9:0.24472218164;NHLH1,2:0.242630198895;SNAI1..3:0.23245277771;HOX{A5,B5}:0.208787940472;GCM1,2:0.205770771382;EGR1..3:0.205008033758;TGIF1:0.201610650806;MED-1{core}:0.186010233914;ADNP_IRX_SIX_ZHX:0.152861042483;GFI1B:0.125343647105;MAFB:0.0985094212922;RXR{A,B,G}:0.092448243681;NKX3-1:0.0870878807663;SOX5:0.0852711609666;XCPE1{core}:0.0546830572024;TBP:0.0544795573188;ZNF148:0.0232576968407;TFDP1:0.00650892769952;ZFP161:-0.0275441838531;HNF4A_NR2F1,2:-0.0276050954865;CREB1:-0.0292891341986;LMO2:-0.0403505706201;SOX2:-0.0684292740425;NR5A1,2:-0.0822077570055;NKX6-1,2:-0.0903890151831;DMAP1_NCOR{1,2}_SMARC:-0.126734063972;GTF2I:-0.141856621769;MZF1:-0.207266382651;MTF1:-0.234193669917;PBX1:-0.234897622789;TEAD1:-0.235560413264;FOXM1:-0.252790933489;GTF2A1,2:-0.275064127433;FOS_FOS{B,L1}_JUN{B,D}:-0.284135458077;TFCP2:-0.290315557553;T:-0.301673963751;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-0.31608697632;TLX1..3_NFIC{dimer}:-0.345923877175;ZNF143:-0.356435078844;PAX1,9:-0.365752084598;MYOD1:-0.36758738694;SREBF1,2:-0.380814092409;TEF:-0.389092282625;ATF6:-0.397420134221;MYFfamily:-0.440822601272;SP1:-0.493464337915;PRDM1:-0.500855766048;SOX{8,9,10}:-0.5095813323;ZIC1..3:-0.534012299047;FOX{D1,D2}:-0.550192122694;POU2F1..3:-0.591857996659;FOX{I1,J2}:-0.593661946616;STAT2,4,6:-0.602039582263;PDX1:-0.615112770108;FOXQ1:-0.660721634612;MAZ:-0.687032423596;RREB1:-0.688497889341;MEF2{A,B,C,D}:-0.696544524034;MYBL2:-0.701923421365;NKX2-3_NKX2-5:-0.702291554617;NFIX:-0.715447577596;PITX1..3:-0.730018561914;GZF1:-0.777148534573;E2F1..5:-0.797300097811;SRF:-0.801091698281;FOSL2:-0.833371549656;EBF1:-0.854185066778;NFKB1_REL_RELA:-0.869613248369;TLX2:-0.874972039792;FOXA2:-0.900157341363;ETS1,2:-0.959232453989;KLF4:-0.993774118396;SPZ1:-1.00393172389;NFATC1..3:-1.03859435952;ONECUT1,2:-1.03974409005;IRF1,2:-1.09540361293;POU5F1:-1.14296502993;TOPORS:-1.15012246377;ELK1,4_GABP{A,B1}:-1.15876946182;LHX3,4:-1.17167078176;RUNX1..3:-1.17963796366;HOX{A4,D4}:-1.20987221058;ZNF238:-1.21597543038;RXRA_VDR{dimer}:-1.23044328124;FOX{F1,F2,J1}:-1.23508671323;RXR{A,B,G}_{NR1H2,PPAR}dimers:-1.24914851985;ZNF423:-1.29149876422;ZBTB16:-1.30729917159;NFE2L2:-1.31071765576;FOXD3:-1.322178713;TFAP4:-1.32394111194;BACH2:-1.33265084232;SPIB:-1.33756203493;HMGA1,2:-1.35160798735;IKZF1:-1.36201305759;IKZF2:-1.39988076579;GATA6:-1.41406807988;NANOG{mouse}:-1.42636586363;RORA:-1.43342941647;HMX1:-1.44275679737;NFE2:-1.44823188932;GATA4:-1.48142461315;CRX:-1.4925297275;DBP:-1.49585109691;CEBPA,B_DDIT3:-1.5044029627;IRF7:-1.50560535752;EP300:-1.56408226507;ELF1,2,4:-1.56457301487;AIRE:-1.64124727198;FOXP1:-1.671932183;LEF1_TCF7_TCF7L1,2:-1.68408789204;ZNF384:-1.68926097361;TP53:-1.69317411013;NR6A1:-1.72270354223;EN1,2:-1.7240413086;EVI1:-1.8018519103;NKX2-1,4:-1.82518735913;PAX8:-1.87993882135;SPI1:-1.89897429862;YY1:-1.90871880648;ALX4:-1.93393674401;TAL1_TCF{3,4,12}:-1.94801974518;CDC5L:-1.94983862868;VSX1,2:-2.03040931956;NANOG:-2.21989727846;PAX2:-2.32093293547;POU3F1..4:-2.33605000546;ALX1:-2.48225940365;STAT5{A,B}:-2.49595688861;FOXL1:-2.50408861296;ARID5B:-2.7865703865;BPTF:-2.84279573865;UFEwm:-2.85443467645;POU1F1:-2.93210494152;NKX2-2,8:-3.02700115326;PAX4:-3.07286980634;CDX1,2,4:-3.15546092703;FOXP3:-3.46263248082
|top_motifs=JUN:5.6915083538;SOX17:5.358292647;HLF:4.77768514715;RFX2..5_RFXANK_RFXAP:4.75200277899;RFX1:4.5617862975;MYB:4.53705025272;ATF2:3.64593667106;HSF1,2:3.57284584026;ESR1:2.90129344504;PPARG:2.53309877243;NFE2L1:2.28758296935;FOXN1:2.28286887152;HBP1_HMGB_SSRP1_UBTF:2.20473348062;NFIL3:2.18174138979;HOXA9_MEIS1:1.68794996479;TBX4,5:1.40970850168;NR1H4:1.17709342086;NR3C1:1.07325017827;ZBTB6:1.03155343269;PAX5:1.02489809041;NRF1:1.00725451332;BREu{core}:0.91469774455;REST:0.850647514045;bHLH_family:0.715522171398;TFAP2{A,C}:0.70922832969;ATF5_CREB3:0.705145086545;ATF4:0.690382436545;HIC1:0.678025160783;PAX6:0.659244820276;STAT1,3:0.637957662372;GLI1..3:0.635984491192;CUX2:0.635516946133;NKX3-2:0.619466382383;NFY{A,B,C}:0.619434338994;HIF1A:0.616409008276;PRRX1,2:0.611993703609;RBPJ:0.60363292854;PATZ1:0.594233728141;ESRRA:0.58795523654;HES1:0.582834868648;TFAP2B:0.574009740051;ZEB1:0.567484714213;AR:0.428232907826;HNF1A:0.373954313919;AHR_ARNT_ARNT2:0.364109717386;FOXO1,3,4:0.356702000803;POU6F1:0.338550358847;OCT4_SOX2{dimer}:0.33190447989;MTE{core}:0.27085953884;HAND1,2:0.263080264516;GFI1:0.259346090379;SMAD1..7,9:0.24472218164;NHLH1,2:0.242630198895;SNAI1..3:0.23245277771;HOX{A5,B5}:0.208787940472;GCM1,2:0.205770771382;EGR1..3:0.205008033758;TGIF1:0.201610650806;MED-1{core}:0.186010233914;ADNP_IRX_SIX_ZHX:0.152861042483;GFI1B:0.125343647105;MAFB:0.0985094212922;RXR{A,B,G}:0.092448243681;NKX3-1:0.0870878807663;SOX5:0.0852711609666;XCPE1{core}:0.0546830572024;TBP:0.0544795573188;ZNF148:0.0232576968407;TFDP1:0.00650892769952;ZFP161:-0.0275441838531;HNF4A_NR2F1,2:-0.0276050954865;CREB1:-0.0292891341986;LMO2:-0.0403505706201;SOX2:-0.0684292740425;NR5A1,2:-0.0822077570055;NKX6-1,2:-0.0903890151831;DMAP1_NCOR{1,2}_SMARC:-0.126734063972;GTF2I:-0.141856621769;MZF1:-0.207266382651;MTF1:-0.234193669917;PBX1:-0.234897622789;TEAD1:-0.235560413264;FOXM1:-0.252790933489;GTF2A1,2:-0.275064127433;FOS_FOS{B,L1}_JUN{B,D}:-0.284135458077;TFCP2:-0.290315557553;T:-0.301673963751;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-0.31608697632;TLX1..3_NFIC{dimer}:-0.345923877175;ZNF143:-0.356435078844;PAX1,9:-0.365752084598;MYOD1:-0.36758738694;SREBF1,2:-0.380814092409;TEF:-0.389092282625;ATF6:-0.397420134221;MYFfamily:-0.440822601272;SP1:-0.493464337915;PRDM1:-0.500855766048;SOX{8,9,10}:-0.5095813323;ZIC1..3:-0.534012299047;FOX{D1,D2}:-0.550192122694;POU2F1..3:-0.591857996659;FOX{I1,J2}:-0.593661946616;STAT2,4,6:-0.602039582263;PDX1:-0.615112770108;FOXQ1:-0.660721634612;MAZ:-0.687032423596;RREB1:-0.688497889341;MEF2{A,B,C,D}:-0.696544524034;MYBL2:-0.701923421365;NKX2-3_NKX2-5:-0.702291554617;NFIX:-0.715447577596;PITX1..3:-0.730018561914;GZF1:-0.777148534573;E2F1..5:-0.797300097811;SRF:-0.801091698281;FOSL2:-0.833371549656;EBF1:-0.854185066778;NFKB1_REL_RELA:-0.869613248369;TLX2:-0.874972039792;FOXA2:-0.900157341363;ETS1,2:-0.959232453989;KLF4:-0.993774118396;SPZ1:-1.00393172389;NFATC1..3:-1.03859435952;ONECUT1,2:-1.03974409005;IRF1,2:-1.09540361293;POU5F1:-1.14296502993;TOPORS:-1.15012246377;ELK1,4_GABP{A,B1}:-1.15876946182;LHX3,4:-1.17167078176;RUNX1..3:-1.17963796366;HOX{A4,D4}:-1.20987221058;ZNF238:-1.21597543038;RXRA_VDR{dimer}:-1.23044328124;FOX{F1,F2,J1}:-1.23508671323;RXR{A,B,G}_{NR1H2,PPAR}dimers:-1.24914851985;ZNF423:-1.29149876422;ZBTB16:-1.30729917159;NFE2L2:-1.31071765576;FOXD3:-1.322178713;TFAP4:-1.32394111194;BACH2:-1.33265084232;SPIB:-1.33756203493;HMGA1,2:-1.35160798735;IKZF1:-1.36201305759;IKZF2:-1.39988076579;GATA6:-1.41406807988;NANOG{mouse}:-1.42636586363;RORA:-1.43342941647;HMX1:-1.44275679737;NFE2:-1.44823188932;GATA4:-1.48142461315;CRX:-1.4925297275;DBP:-1.49585109691;CEBPA,B_DDIT3:-1.5044029627;IRF7:-1.50560535752;EP300:-1.56408226507;ELF1,2,4:-1.56457301487;AIRE:-1.64124727198;FOXP1:-1.671932183;LEF1_TCF7_TCF7L1,2:-1.68408789204;ZNF384:-1.68926097361;TP53:-1.69317411013;NR6A1:-1.72270354223;EN1,2:-1.7240413086;EVI1:-1.8018519103;NKX2-1,4:-1.82518735913;PAX8:-1.87993882135;SPI1:-1.89897429862;YY1:-1.90871880648;ALX4:-1.93393674401;TAL1_TCF{3,4,12}:-1.94801974518;CDC5L:-1.94983862868;VSX1,2:-2.03040931956;NANOG:-2.21989727846;PAX2:-2.32093293547;POU3F1..4:-2.33605000546;ALX1:-2.48225940365;STAT5{A,B}:-2.49595688861;FOXL1:-2.50408861296;ARID5B:-2.7865703865;BPTF:-2.84279573865;UFEwm:-2.85443467645;POU1F1:-2.93210494152;NKX2-2,8:-3.02700115326;PAX4:-3.07286980634;CDX1,2,4:-3.15546092703;FOXP3:-3.46263248082
|xref=
}}
}}

Revision as of 15:17, 27 June 2012


Name:Clontech Mouse Universal Reference Total RNA, pool1
Species:Mouse (Mus musculus)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainNA
tissuewhole body
dev stageUNDEFINED
sexmixed
ageNA
cell typeCELL MIXTURE - tissue sample
cell lineNA
companyClontech
collaborationFANTOM5 OSC CORE (contact: Al Forrest)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot number8092682
catalog numberCat:636657
sample typetotal RNA
extraction protocol (Details)OP-RNA-extraction-totalRNA-TRIzol-isopropanol-v1.0
Download raw sequence, BAM & CTSS
Mm9
BAMCTSS
[{{{mm9bam}}} download][{{{mm9ctss}}} donwload]
Mm10
BAMCTSS
[{{{mm10bam}}} download][{{{mm10ctss}}} donwload]


Relative expression to median (log10)

Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.



Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data

CNhs10609

00.715
10.323
100
1000
10000.0652
10010.0244
1002-0.0343
1003-0.00177
10040.236
10050.0354
10060.259
10070.0894
10080
10090.168
101-0.0613
10100.0354
10110.692
10120.0682
10130.0807
1014-0.0851
10150.122
1016-0.0769
10170
10180.0682
10190.0354
1020
10200
10210
10220.217
10230
10240.233
10250.373
10260.581
10270.131
10280.0354
1029-0.0307
1030.00251
10300
1031-0.0963
10320.053
10330.0322
10340.125
10350.247
1036-0.238
10370
10380.0329
10390.179
1040
10400.082
10410.225



Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample

JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10609

Jaspar motifP-value
MA0002.20.26
MA0003.10.159
MA0004.10.81
MA0006.10.0516
MA0007.10.746
MA0009.10.309
MA0014.10.913
MA0017.10.592
MA0018.22.88425e-14
MA0019.10.0969
MA0024.10.346
MA0025.10.00866
MA0027.10.0693
MA0028.10.0117
MA0029.10.672
MA0030.10.374
MA0031.10.913
MA0035.20.00266
MA0038.10.375
MA0039.20.468
MA0040.10.279
MA0041.10.0618
MA0042.10.353
MA0043.10.00211
MA0046.10.00346
MA0047.20.265
MA0048.10.835
MA0050.10.0197
MA0051.10.967
MA0052.10.0616
MA0055.10.0454
MA0057.10.364
MA0058.10.897
MA0059.10.478
MA0060.16.26947e-5
MA0061.12.34811e-4
MA0062.21.0206e-5
MA0065.20.523
MA0066.10.411
MA0067.10.411
MA0068.10.222
MA0069.10.197
MA0070.10.97
MA0071.10.755
MA0072.10.27
MA0073.10.942
MA0074.10.547
MA0076.10.0668
MA0077.15.72116e-5
MA0078.18.26167e-10
MA0079.20.686
MA0080.21.44718e-5
MA0081.10.00323
MA0083.10.387
MA0084.10.554
MA0087.10.0301
MA0088.10.402
MA0090.10.143
MA0091.10.994
MA0092.10.0993
MA0093.10.941
MA0099.20.134
MA0100.12.94888e-22
MA0101.10.00555
MA0102.20.495
MA0103.10.166
MA0104.24.70328e-4
MA0105.12.07987e-7
MA0106.11.70295e-4
MA0107.10.00145
MA0108.20.821
MA0111.10.0386
MA0112.20.0726
MA0113.10.611
MA0114.10.301
MA0115.10.917
MA0116.10.0201
MA0117.10.95
MA0119.10.341
MA0122.10.666
MA0124.10.619
MA0125.10.453
MA0131.10.492
MA0135.10.793
MA0136.12.5896e-5
MA0137.20.101
MA0138.20.37
MA0139.10.432
MA0140.13.39424e-7
MA0141.10.335
MA0142.10.498
MA0143.13.38138e-4
MA0144.10.227
MA0145.10.18
MA0146.10.0203
MA0147.10.00513
MA0148.10.133
MA0149.10.491
MA0150.10.659
MA0152.10.0808
MA0153.10.151
MA0154.10.0539
MA0155.10.244
MA0156.11.22068e-6
MA0157.10.381
MA0159.10.543
MA0160.10.0011
MA0162.10.582
MA0163.10.363
MA0164.10.726
MA0258.10.499
MA0259.10.16



FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10609

Novel motifP-value
10.915
100.389
1000.308
1010.3
1020.353
1030.547
1040.899
1050.929
1060.00252
1070.0468
1080.449
1090.947
110.656
1100.689
1110.862
1120.497
1130.856
1140.395
1150.904
1160.917
1170.514
1180.551
1190.667
120.867
1200.657
1210.0271
1220.615
1230.371
1240.855
1250.735
1260.924
1270.202
1280.0167
1290.444
130.00371
1300.934
1310.824
1320.683
1330.423
1340.969
1350.1
1360.00394
1370.385
1380.989
1390.333
140.649
1400.064
1410.142
1420.727
1430.529
1440.27
1450.834
1460.199
1470.368
1480.298
1490.389
150.671
1500.803
1510.372
1520.521
1530.806
1540.315
1550.462
1561.84924e-5
1570.987
1581.38689e-5
1590.0548
1600.0135
1610.23
1620.48
1630.733
1640.49
1650.477
1660.471
1670.639
1680.791
1690.543
170.49
180.473
190.426
20.074
200.275
210.531
220.949
230.499
240.0694
250.438
260.0485
270.0435
280.459
290.848
30.322
300.825
310.414
320.737
330.618
340.225
350.665
360.335
370.0688
380.73
390.497
40.992
400.0822
415.29361e-4
420.497
430.29
440.767
450.734
460.312
470.0627
480.245
490.815
50.347
500.578
510.656
520.662
530.983
540.489
550.807
560.157
570.48
580.402
590.5
60.756
600.347
610.345
620.6
630.578
640.691
650.527
660.152
670.257
680.785
690.425
70.442
700.814
710.00348
720.329
730.243
740.786
750.17
760.4
770.748
782.14088e-6
790.963
80.016
800.533
810.301
820.916
830.658
840.682
850.891
860.287
870.00114
880.282
890.874
90.971
900.629
910.52
920.518
930.683
940.418
950.9
960.774
970.154
980.956
990.912



de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br> library id: CNhs10609


FANTOM5 (FF) ontology

Direct parent terms


Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data

UBERON: Anatomy
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)

FF: FANTOM5
NA

Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=FF:10001-101A3&oldid=1839690"